Verano Holdings (VRNO) Revenue (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Revenue of $208.2 million for Q1 2026, down 0.78% year-over-year from $209.8 million in Q1 2025, and up 0.76% quarter-over-quarter from $206.6 million in Q4 2025.
Verano Holdings (VRNO) Revenue (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Revenue for 6 consecutive years, with $208.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue fell 0.78% year-over-year to $208.2 million; the TTM figure through Mar 2026 stood at $819.9 million (down 5.45% YoY), while the FY2025 annual figure was $821.5 million, down 6.5% from the prior year.
- Revenue advanced to $208.2 million in Q1 2026 per VRNO's latest filing, from $206.6 million in the prior quarter.
- Across five years, Revenue topped out at $240.1 million in Q3 2023 and bottomed at $854000.0 in Q1 2024.
- Historically, Revenue has averaged $206.2 million across 5 years, with a median of $218.2 million in 2024.
- Annual changes were most pronounced in 2024 — Revenue tumbled 99.62% — and 2025, when it soared 24467.8%.
- Verano Holdings' Revenue stood at $225.9 million in 2022, then grew by 4.98% to $237.2 million in 2023, then fell by 8.0% to $218.2 million in 2024, then dropped by 5.31% to $206.6 million in 2025, then increased by 0.76% to $208.2 million in 2026.
- Business Quant data shows VRNO's Revenue at $208.2 million in Q1 2026, $206.6 million in Q4 2025, and $202.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Verano Holdings | 441.01 Mn | 355.81 Mn | 99.70 Mn | 217.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 217.92 Mn |
| Mar 31, 2026 | 208.18 Mn |
| Dec 31, 2025 | 206.61 Mn |
| Sep 30, 2025 | 202.81 Mn |
| Jun 30, 2025 | 202.27 Mn |
| Mar 31, 2025 | 209.81 Mn |
| Dec 31, 2024 | 218.21 Mn |
| Sep 30, 2024 | 216.68 Mn |
| Jun 30, 2024 | 222.39 Mn |
| Mar 31, 2024 | 854,000.00 |
| Dec 31, 2023 | 237.19 Mn |
| Sep 30, 2023 | 240.09 Mn |
| Jun 30, 2023 | 234.12 Mn |
| Mar 31, 2023 | 227.06 Mn |
| Dec 31, 2022 | 225.93 Mn |
| Sep 30, 2022 | 227.59 Mn |
| Jun 30, 2022 | 223.66 Mn |
| Mar 31, 2022 | 202.24 Mn |
| Dec 31, 2021 | 211.42 Mn |
| Sep 30, 2021 | 206.47 Mn |